Zanosar

Zanosar (streptozocin) is an antineoplastic agent used in chemotherapy. This intravenous medication is prescribed for pancreatic neuroendocrine tumors. Explore its therapeutic role and handling guidance for informed use.

Zanosar is primarily used to treat pancreatic neuroendocrine tumors, including pancreatic islet cell carcinoma. It belongs to the class of alkylating agents and is administered intravenously under medical supervision. Patients often inquire about what Zanosar is used for, particularly in managing specific types of cancer.

Zanosar works by interfering with the growth of cancer cells, though it may also affect healthy cells. Common effects include nausea, vomiting, or fatigue during treatment. Some patients report changes in kidney function, which are monitored closely by healthcare providers.

Zanosar requires careful handling due to its cytotoxic properties. It should be administered by healthcare professionals in a controlled setting. Patients are advised to stay hydrated and report any unusual symptoms, such as persistent nausea or signs of infection, immediately.

Zanosar may interact with other medications, including those metabolized by the liver or affecting kidney function. Alcohol and certain vaccines should be avoided during treatment. Always inform your doctor about all medications and supplements you are taking.